Umemura, K <br/><br/>
Evaluation of the combination of a tissue-type plasminogen activator, SUN9216, and a thromboxane A2 receptor antagonist, vapiprost, in a rat middle cerebral artery thrombosis model.  [electronic resource] 

 -  Stroke  Jul 1993 
 - 1077-81; discussion 1081-2 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0039-2499 
<br/><br/><label>Standard No.: </label>10.1161/01.str.24.7.1077  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Biphenyl Compounds--pharmacology<br/>Cerebral Infarction--drug therapy<br/>Disease Models, Animal<br/>Drug Combinations<br/>Drug Evaluation, Preclinical<br/>Heptanoic Acids--pharmacology<br/>Intracranial Embolism and Thrombosis--drug therapy<br/>Male<br/>Plasminogen Activators--pharmacology<br/>Rats<br/>Rats, Wistar<br/>Receptors, Thromboxane--antagonists & inhibitors<br/>Time Factors<br/>Tissue Plasminogen Activator--pharmacology